Project Number 1U01AG076481-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator ZHANG, SHIJUN Principal Investigator First Name SHIJUN Principal Investigator Last Name ZHANG Awardee Organization VIRGINIA COMMONWEALTH UNIVERSITY Awardee State Virginia Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $1,426,573 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
